Literature DB >> 21518969

The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Galina V Petrova1, Elena N Naumova, Jack Gorski.   

Abstract

Cross-reactivity of T cells is defined as recognition of two or more peptide-MHC complexes by the same T cell. Although examples of cross-reactivity have been reported, a detailed examination of cross-reactivity has not been performed. In this study, we took advantage of the high degree of polyclonality in the BV19 T cell repertoire responding to influenza M1(58-66) in HLA-A2 individuals to obtain a measure of simple cross-reactivity. We used substitutions that incrementally change the structure of the M1(58-66) peptide to measure how the HLA-A2-restricted response adapts to these changes. In three HLA-A2 adult subjects, we identified the BV19 clonotypes in the recall response to the influenza epitope M1(58-66) and 12 M1 peptides substituted at TCR contact position 63 or 65. The fraction of cross-reactive clonotypes in the M1(58-66) repertoire varied from 45-58% in the three donors. The extent of cross-reactivity, which is the additional number of peptides recognized by a single clonotype, is as high as six. We summarized the data using graph theory, with the cross-reactive clonotypes connecting the different HLA-A2 peptides recognized. The cross-reactive clonotypes form a well-connected network that could provide protection from virus-escape variants. We predict that any new pathogen with an epitope whose shape corresponds to that of the peptides that we studied would find a pre-existing repertoire ready to respond to it. We propose that in adult memory repertoires, previously encountered epitopes may have generated similar cross-reactive repertoires.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518969      PMCID: PMC4513670          DOI: 10.4049/jimmunol.1004031

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.

Authors:  H D Chen; A E Fraire; I Joris; M A Brehm; R M Welsh; L K Selin
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

Review 2.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.

Authors:  Michael A Brehm; Amelia K Pinto; Keith A Daniels; Jonathan P Schneck; Raymond M Welsh; Liisa K Selin
Journal:  Nat Immunol       Date:  2002-06-03       Impact factor: 25.606

Review 4.  T cell receptors: affinities, cross-reactivities, and a conformer model.

Authors:  Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

5.  A structural basis for immunodominant human T cell receptor recognition.

Authors:  Guillaume B E Stewart-Jones; Andrew J McMichael; John I Bell; David I Stuart; E Yvonne Jones
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

6.  The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.

Authors:  M A Bednarek; S Y Sauma; M C Gammon; G Porter; S Tamhankar; A R Williamson; H J Zweerink
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

7.  A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: implications for establishing memory T cell repertoires in "real-world" conditions.

Authors:  Y N Naumov; K T Hogan; E N Naumova; J T Pagel; J Gorski
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

8.  Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus.

Authors:  Victoria Kasprowicz; Scott M Ward; Alison Turner; Alexandros Grammatikos; Brian E Nolan; Lia Lewis-Ximenez; Charles Sharp; Jenny Woodruff; Vicki M Fleming; Stuart Sims; Bruce D Walker; Andrew K Sewell; Georg M Lauer; Paul Klenerman
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.

Authors:  P J Lehner; E C Wang; P A Moss; S Williams; K Platt; S M Friedman; J I Bell; L K Borysiewicz
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals.

Authors:  Paula M Acierno; Danforth A Newton; Edwin A Brown; Lou Anne Maes; John E Baatz; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2003-08-14       Impact factor: 5.531

View more
  9 in total

1.  Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.

Authors:  Jiezuan Yang; Jiajia Chen; Jianqin He; Yirui Xie; Yixing Zhu; Hongcui Cao; Lanjuan Li
Journal:  Cell Mol Immunol       Date:  2014-07       Impact factor: 11.530

Review 2.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

3.  CDR3 motif generation and selection in the BV19-utilizing subset of the human CD8 T cell repertoire.

Authors:  Maryam B Yassai; Wendy Demos; Jack Gorski
Journal:  Mol Immunol       Date:  2016-03-07       Impact factor: 4.407

4.  CDR3 clonotype and amino acid motif diversity of BV19 expressing circulating human CD8 T cells.

Authors:  Maryam B Yassai; Wendy Demos; Teresa Janczak; Elena N Naumova; Jack Gorski
Journal:  Hum Immunol       Date:  2015-11-24       Impact factor: 2.850

5.  Cross-reactive responses to modified M1₅₈-₆₆ peptides by CD8⁺ T cells that use noncanonical BV genes can describe unknown repertoires.

Authors:  Galina V Petrova; Jack Gorski
Journal:  Eur J Immunol       Date:  2012-09-20       Impact factor: 5.532

6.  Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy.

Authors:  Dinler A Antunes; Maurício M Rigo; Martiela V Freitas; Marcus F A Mendes; Marialva Sinigaglia; Gregory Lizée; Lydia E Kavraki; Liisa K Selin; Markus Cornberg; Gustavo F Vieira
Journal:  Front Immunol       Date:  2017-10-04       Impact factor: 7.561

7.  Exploring and analysing single cell multi-omics data with VDJView.

Authors:  Jerome Samir; Simone Rizzetto; Money Gupta; Fabio Luciani
Journal:  BMC Med Genomics       Date:  2020-02-18       Impact factor: 3.063

8.  Role of cross-reactivity in cellular immune targeting of influenza A M158-66 variant peptide epitopes.

Authors:  Galina V Petrova; Yuri N Naumov; Elena N Naumova; Jack Gorski
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

Review 9.  Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors.

Authors:  Chloe H Lee; Mariolina Salio; Giorgio Napolitani; Graham Ogg; Alison Simmons; Hashem Koohy
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.